151 related articles for article (PubMed ID: 22127362)
41. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
43. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum.
Marnitz S; Schmittel A; Bolbrinker J; Schmidt FP; Fons G; Kalache K; Schneider A; Köhler C
Fertil Steril; 2009 Nov; 92(5):1748.e1-4. PubMed ID: 19765705
[TBL] [Abstract][Full Text] [Related]
44. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy.
Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C
Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559
[TBL] [Abstract][Full Text] [Related]
45. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
[TBL] [Abstract][Full Text] [Related]
46. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
[TBL] [Abstract][Full Text] [Related]
47. Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.
Marnitz S; Schram J; Budach V; Sackerer I; Vercellino GF; Sehouli J; Köhler C
Strahlenther Onkol; 2015 May; 191(5):421-8. PubMed ID: 25413986
[TBL] [Abstract][Full Text] [Related]
48. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
49. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
50. Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer.
Mitsuhashi A; Uno T; Usui H; Tate S; Hirashiki K; Kato K; Kiyohara H; Kato S; Ito H; Shozu M
Anticancer Res; 2010 Jun; 30(6):2341-6. PubMed ID: 20651390
[TBL] [Abstract][Full Text] [Related]
51. A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy.
Nyongesa C; Ruff P; Donde B; Kotzen J
Int J Gynecol Cancer; 2006; 16(4):1614-9. PubMed ID: 16884375
[TBL] [Abstract][Full Text] [Related]
52. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
Azria E; Morice P; Haie-Meder C; Thoury A; Pautier P; Lhomme C; Duvillard P; Castaigne D
Ann Surg Oncol; 2005 Apr; 12(4):332-7. PubMed ID: 15827678
[TBL] [Abstract][Full Text] [Related]
53. [The guidelines for diagnostics and treatment of cervical cancer].
Inciūra A; Juozaityte E
Medicina (Kaunas); 2004; 40(4):394-403. PubMed ID: 15111756
[TBL] [Abstract][Full Text] [Related]
54. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer.
Cheewakriangkrai C; Srisomboon J; Chitapanarux I; Suprasert P; Phongnarisorn C; Siriaree S; Charoenkwan K
J Med Assoc Thai; 2005 Oct; 88(10):1331-7. PubMed ID: 16519375
[TBL] [Abstract][Full Text] [Related]
55. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
56. Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer.
Houvenaeghel G; Lelievre L; Rigouard AL; Buttarelli M; Jacquemier J; Viens P; Gonzague-Casabianca L
Gynecol Oncol; 2006 Jul; 102(1):74-9. PubMed ID: 16406062
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
58. Retrospective analysis of concomitant Cisplatin during radiation in patients aged 55 years or older for treatment of advanced cervical cancer: a gynecologic oncology group study.
Kunos C; Tian C; Waggoner S; Rose PG; Lanciano R
Int J Gynecol Cancer; 2009 Oct; 19(7):1258-63. PubMed ID: 19823064
[TBL] [Abstract][Full Text] [Related]
59. Radical vaginal hysterectomy with extraperitoneal pelvic lymphadenectomy in cervical cancer.
Savino L; Borruto F; Comparetto C; Massi GB
Eur J Gynaecol Oncol; 2001; 22(1):31-5. PubMed ID: 11321490
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.
Gemer O; Lavie O; Gdalevich M; Eitan R; Mamanov E; Piura B; Rabinovich A; Levavi H; Saar-Ryss B; Halperin R; Finci S; Beller U; Bruchim I; Levy T; Meirovitz A; Shachar IB; Arie AB
Am J Clin Oncol; 2016 Feb; 39(1):37-42. PubMed ID: 25734407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
